Web Results

Gilead (GILD) Lags Q1 Earnings & Revenues, '16 View Intact - April ...

www.zacks.com/stock/news/215428/gilead-gild-lags-q1-earnings-amp-revenues-16-view-intact

Apr 29, 2016 ... Gilead Sciences (GILD) reported lower-than-expected first-quarter 2016 earnings (including ... Gilead's blockbuster hepatitis C virus (HCV) drug, Harvoni, plunged 15.7% year over year to ... Today, you can download 7 Best Stocks for the Next 30 Days. ... China Stock Roundup: Solar Companies in Focus ...

Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in ...

finance.yahoo.com/news/biotech-stock-roundup-gilead-hiv-193507826.html

Mar 2, 2016 ... Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in ... The fourth quarter earnings season is winding down, with quite a ... Gilead is quite focused on bringing new HIV treatments to market and to boost sales of its blockbuster HIV ... T cell therapies targeting areas of major unmet need in cancer.

Deutsche Bank's Top Stocks for This Quarter and 2015 Include ...

247wallst.com/investing/2014/10/08/deutsche-banks-top-stocks-to-buy-now-for-this-quarter-and-2015/

Oct 8, 2014 ... Deutsche Bank's Top Stocks to Buy Now for This Quarter and 2015 ... Gilead trades at just 8.8 times 2016 earnings, versus the company's peers, ... The iPhone 6 has already proven to be a blockbuster product, which should bode well for Micron. ... How Much Money Does Monsanto Make From Roundup?

Friday, April 29, 2016 | Kaiser Health News

khn.org/morning-briefing/friday-april-29-2016/

Apr 29, 2016 ... Health Policy Research; Research Roundup: New Medicare Doc Pay; ... Keep in mind that we give extra points if you link back to a KHN original story. ..... Aetna's first-quarter earnings slid nearly 7 percent as enrollment ... The drugmaker Gilead Sciences has seen its fortunes buoyed by its blockbuster ...

Biotech Industry - MarketWatch

www.marketwatch.com/industries/biotech

Young served for 10 years as Gilead's vice president of commerical ... Samsung Group said Tuesday its near-replica of Johnson & Johnson's blockbuster arthritis drug Remicade has ... Weekly roundup: Regrets of older Americans | A nasty family battle | Feeding the ... McDonald's Eyes New Big Mac as Key to Earnings 2 :32.

Drug Channels: October 2014

www.drugchannels.net/2014_10_01_archive.html

Oct 1, 2014 ... Time for my Halloween-themed roundup of Drug Channels news stories. ... Yesterday, Gilead Sciences reported another blockbuster quarter for Sovaldi sales. ... Based on the chart below, I think you'll agree that Sovaldi is the most ... which should—but probably won't—mute critics of preferred networks.

Evaluate in the press and latest industry reports | Evaluate

www.evaluategroup.com/public/Buzz.aspx

Jan 12, 2015 ... "A recent roundup of top drugs in the clinic by Evaluate Pharma pegged ... "The treatment has long been pegged as a blockbuster in waiting, with 2020 ... Five things you need to know today, and hide the children, it's St. Patrick's Day .... sales, but Alcon's sales fell 13% to $2.3bn in the fourth ...

ICPT Stock Quote - Intercept Pharmaceuticals Inc. Stock Price Today ...

www.marketwatch.com/investing/stock/icpt

Updated stock quote for icpt - including icpt stock price today, earnings and ... Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well ... Intercept to Report First Quarter 2016 Financial Results on May 5 .... 5 things rich people do with money — that you should be doing. 1:51p.

Biotechnology - MarketWatch.com Topics

www.marketwatch.com/topics/subjects/biotechnology

How a Bayer-Monsanto merger will wind up costing you at the grocery store ... Young served for 10 years as Gilead's vice president of commerical ... Johnson's blockbuster arthritis drug Remicade has been accepted for review ... Weekly roundup: Regrets of older Americans | A nasty family battle | Feeding the rich in Vegas.

GEN's Annual Wall Street Analyst Roundup | GEN Magazine Articles ...

www.genengnews.com/gen-articles/gen-s-annual-wall-street-analyst-roundup/2355/

Describe the current state of the industry and what trends you see for 2008. ... FDA approval to market a new drug is now needed to lure backers. ... Over the next few quarters, for Biogen Idec stock to perform well, aside from speculation ... We continue to believe that Gilead Sciences (GILD) is the best managed large- cap ...

More Info

Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings - April 26 ...

www.zacks.com

Apr 26, 2016 ... Gilead Sciences (GILD), which is set to report first-quarter 2016 ... Gilead's blockbuster hepatitis C virus (HCV) drug Harvoni should ... Here are a couple of other health care stocks that you may want to ... Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well.

3 Things to Watch With Gilead Sciences - The Motley Fool

www.fool.com

Jul 9, 2012 ... These factors could hold the key to big gains with Gilead Sciences. ... $1.84 billion of Gilead's $2.21 billion in net product sales in the first-quarter. ... Just in case you weren't aware, the race to create the next blockbuster ... Foolish roundup. Now that you know what to watch for, it should be easier to an...

Pharmaceutical industry gets high on fat profits - BBC News - BBC.com

www.bbc.com

Nov 6, 2014 ... When do you cross the line from essential profits to profiteering? ... Gilead clocked sales of $3.5bn for its latest blockbuster hepatitis C drug Sovaldi. ... cured , will never need surgery or looking after, and can continue to support their families. ... For a drug raking in $3bn a quarter, even a one-month extension ...